USC.edu
Are You a Patient?

Marlena Fejzo, PhD

Clinical Assistant Professor of Population and Public Health Sciences in the Center for Genetic Epidemiology

Image of Marlena Fejzo, PhD
Websites
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Overview

Marlena Fejzo is a Harvard-trained women’s health scientist who has published peer-reviewed articles on many diseases of women including ovarian and breast cancer, multiple sclerosis, and discovered the first genes for uterine fibroids, nausea and vomiting of pregnancy (NVP), and hyperemesis gravidarum (HG). Fejzo is a Clinical Professor at the University of Southern California, Chief Scientific Officer of The Morning Sickness and HG Clinic, Research Advisor of the HER Foundation, Board Member of the Foundation for Women’s Health, Member of the Women’s Health Network, and an advisor for NGM Bio. Fejzo is a 2024 Time Woman of the Year and Time 100 Health Honoree, received the National Organization of Women Victoria Mastrobuono Award in Women’s Health, Forbes 50-Over-50 award in Innovation, is a Falling Walls Breakthrough of the Year Finalist, and the inaugural BII & Science Translational Medicine Prize for Innovations in Women’s Health grand prize winner.

Publications

  • KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition. Br J Cancer. 2014 Oct 28; 111(9):1788-801.. View in PubMed
  • POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer. Gynecol Oncol. 2014 Feb; 132(2):334-42.. View in PubMed
  • Antihistamines and other prognostic factors for adverse outcome in hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 2013 Sep; 170(1):71-6.. View in PubMed
  • Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab. PLoS One. 2013; 8(2):e56112.. View in PubMed
  • Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer. Int J Mol Sci. 2013 Feb 01; 14(2):3094-109.. View in PubMed
  • No increased risk of psychological/behavioral disorders in siblings of women with hyperemesis gravidarum (HG) unless their mother had HG. J Dev Orig Health Dis. 2012 Oct; 3(5):375-9.. View in PubMed
  • Hyperemesis gravidarum: it is time to put an end to the misguided theory of a psychiatric etiology. Gen Hosp Psychiatry. 2012 Nov-Dec; 34(6):699-700.. View in PubMed
  • Change in paternity and recurrence of hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2012 Aug; 25(8):1241-5.. View in PubMed
  • Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2012 Jun; 25(6):632-6.. View in PubMed
  • Prenatal exposure to hyperemesis gravidarum linked to increased risk of psychological and behavioral disorders in adulthood. J Dev Orig Health Dis. 2011 Aug; 2(4):200-4.. View in PubMed

Similar People